Surgery Partners (NASDAQ:SGRY – Get Free Report) will be issuing its quarterly earnings data before the market opens on Tuesday, November 12th. Analysts expect the company to announce earnings of $0.21 per share for the quarter. Parties interested in participating in the company’s conference call can do so using this link.
Surgery Partners Stock Performance
Shares of NASDAQ SGRY opened at $30.36 on Friday. The firm has a market capitalization of $3.86 billion, a price-to-earnings ratio of -112.44, a PEG ratio of 2.28 and a beta of 2.76. Surgery Partners has a one year low of $22.25 and a one year high of $36.92. The business has a fifty day simple moving average of $31.04 and a 200 day simple moving average of $28.39. The company has a current ratio of 1.83, a quick ratio of 1.69 and a debt-to-equity ratio of 0.96.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on SGRY shares. UBS Group assumed coverage on shares of Surgery Partners in a research note on Monday, October 14th. They issued a “buy” rating and a $38.00 price objective for the company. StockNews.com cut shares of Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Citigroup lowered their price objective on Surgery Partners from $38.00 to $36.00 and set a “buy” rating on the stock in a research note on Wednesday, August 7th. Benchmark reissued a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a report on Monday, August 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $40.13.
Surgery Partners Company Profile
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Stories
- Five stocks we like better than Surgery Partners
- Consumer Staples Stocks, Explained
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
- 3 Warren Buffett Stocks to Buy Now
- MarketBeat Week in Review – 11/4 – 11/8
- What is the Dow Jones Industrial Average (DJIA)?
- Trump’s Return: Which Sectors Will Benefit Most?
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.